The world’s first and largest telehealth platform company, Teladoc Inc (NYSE: TDOC), was introduced to the New York Stock Exchange on June 30. The proprietary company released 8.3 million shares at the price of $19 per share, above the expected range of $15-$17.
Shares skyrocketed on its IPO, moving from $19 to opening at $29.95, well over a 50 percent hike. On Monday, Wall Street analysts initiated coverage on the stock:
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
JP Morgan: Initiated coverage on TDOC with an Overweight rating and a price target of $38.
Deutsche Bank: Buy; PT of $38.
SunTrust Bank: Buy; PT of $37.
William Blair: Outperform.
SUMMARY: 2 Buy, 1 Overweight, and 1 Outperform rating; Price target range $37-$38.